Drug Channels

JANUARY 7, 2025

It's time for Drug Channels annual examination of U.S. brand-name drug pricing. For 2024, average brand-name drugs list prices grew by only 2.3%. Whats more, after adjusting for overall inflation, brand-name drug net prices dropped for an unprecedented seventh consecutive year. The bubble wont vanish overnight.

Pharmacy

New Drug Approvals

JULY 25, 2025

The distinction between it and traditional corticosteroid drugs lies in its capacity to specifically activate particular signaling pathways of corticosteroids. In individuals diagnosed with DMD, the primary mechanism through which corticosteroid drugs exhibit their effectiveness is by exerting anti-inflammatory effects. 70) Keam, S.

FDA

Drug Channels

DECEMBER 12, 2024

This week, Im rerunning some popular posts while I prepare for tomorrows Drug Channels Outlook 2025 live video webinar. Time for DCIs annual update on the channels for provider-administered drugs. drug channels. Read more 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company.

Specialty Pharmacies

Drug Channels

MAY 12, 2025

During my PBM Industry Update: Trends, Challenges, and Whats Ahead video webinar, I explored the latest trends, emerging data, and strategic shifts transforming the pharmacy benefit management (PBM) industry. Understanding how PBMs generate profits is key to navigating the evolving drug channel landscape.

Pharmacy

Drug Channels

FEBRUARY 26, 2025

On March 18, 2025, Drug Channels Institute will release The 2025 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. drug pricing, reimbursement, and dispensing system. prescription drug channels. prescription drug channels. Read on for more details. All rights reserved.

Pharmacy

National Institute on Drug Abuse: Nora's Blog

NOVEMBER 25, 2024

Contrary to worries that syringe services programs (SSPs) will encourage or promote drug use, evidence shows that they more often do the opposite, linking people with addiction to effective treatment and even helping prevent overdose deaths. The common belief that SSPs encourage more drug use is contradicted by the data.

Drugs

Drug Channels

JANUARY 14, 2025

During my recent Drug Channels Outlook 2025 video webinar, I tackled a wide range of crucial topicsincluding the controversial 340B Drug Pricing Program. As I explain in this video excerpt, we may finally see reform of this rapidly expanding program. All rights reserved. This Feed is for personal non-commercial use only.

Pharmacy

Drug Channels

NOVEMBER 4, 2024

Here on Drug Channels , we have long highlighted the boom in provider-administered biosimilars. In contrast to the pharmacy market, adoption of these biosimilars is growing, prices are dropping, and formulary barriers continue to fall. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company.

Biosimilars

Advarra

MARCH 6, 2025

The Value of Clinical Research Clinical research is the engine that drives medical innovation, leading to the discovery of new drugs, treatments and medical devices that enhance patients access to treatment options, improve patient care and outcomes, and transform the healthcare landscape.

Clinical Research

Drug Patent Watch

JANUARY 7, 2025

Generic drugs play a crucial role in providing affordable medication options to patients. As healthcare professionals, it’s our responsibility to educate patients about generic drugs and empower them to make informed decisions about their treatment options. What Are Generic Drugs?

Drugs

FDA Law Blog: Biosimilars

FEBRUARY 18, 2025

Hull A recent DEA decision revoking the registration of a Louisiana pharmacy sheds light on the Agencys approach to crediting one experts testimony over that of another expert during an administrative hearing. In Neumanns Pharmacy, LLC , 90 Fed. By Andrew J.

Testimonials

Drug Channels

MARCH 4, 2025

Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCIs new live video webinar: PBM Industry Update: Trends, Challenges, and What's Ahead This event will be broadcast live on Friday, April 4, 2025, from 12:00 p.m. to 1:30 p.m. WHAT YOU WILL LEARN Join industry expert Adam J.

Pharmacy

The Pharma Data

JUNE 6, 2025

CSOs allow pharmaceutical firms to scale sales operations rapidly , particularly during drug launches , geographic expansions , product lifecycle extensions , and co-promotion agreements. These developments demand a highly skilled, therapeutically trained, and compliance-conscious salesforce —precisely what leading CSOs offer. In the U.S.,

Pharmaceutical Companies

FDA Law Blog: Biosimilars

MAY 19, 2025

We have regularly posted on recognized prescribing red flags that pharmacists have ignored that resulted in administrative or civil actions by the Drug Enforcement Administration (DEA) including against Gulf Med and Coconut Grove pharmacies in Florida and Zarzamora Healthcare LLC in Texas. Houck Last month the U.S. 81, 86, 251.

Doctors

Drug Channels

JULY 8, 2025

The 2025 launch of biosimilars to Johnson & Johnson’s Stelara (ustekinumab) marks another turning point in pharmacy benefit dynamics. But unlike the chaotic rollout of Humira biosimilars, pharmacy benefit managers (PBMs) came prepared. Read more » © 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company.

Biosimilars

BioPharma Drive: Drug Pricing

JULY 28, 2025

Unsuitable for standard retail yet not requiring the full infrastructure of specialty pharmacies, these products face unique access barriers that traditional distribution models cant address effectively. Alternative channels that bring together tech-driven hub services and integrated pharmacy networks to maximize profitable revenue growth.

Specialty Pharmacies

FDA Law Blog: Biosimilars

JUNE 30, 2025

The Federal Controlled Substances Act (“CSA”) and its regulations require Drug Enforcement Administration (“DEA”) registrants to submit certain reports related to narcotic drug transactions, thefts and significant losses, and suspicious orders. Manufacturers must also report selected schedule III and IV psychotropic drugs quarterly.

Pharmacy

Drug Channels

APRIL 16, 2025

Drug Channels Institutes (DCIs) latest analysis reveals that PBM-affiliated specialty pharmacies continue to dominate the dispensing of specialty drugs. DCI has identified nearly 1,900 dispensing locations with specialty pharmacy accreditation. Click here to share your thoughts with the Drug Channels LinkedIn community.

Specialty Pharmacies

Codon

JULY 14, 2025

This history of one of the world’s most widely consumed classes of drugs demonstrates the difficulties that surround the fact-finding of its origins. Firstly, the stories stretch back millennia, and secondly, aspirin is such a successful drug that there is ample material to work with.

Treatment

Perficient: Drug Development

FEBRUARY 11, 2025

This blog post explores the importance of screen reader compatibility in pharmacies, provides practical examples, and discusses why it matters for drug companies’ web pages and mobile applications. This inclusivity is fundamental to providing a positive and equitable customer experience.

Pharmacy

Drug Channels

APRIL 4, 2025

It's time for Drug Channels annual examination of U.S. brand-name drug pricing. For 2024, average brand-name drugs list prices grew by only 2.3%. Whats more, after adjusting for overall inflation, brand-name drug net prices dropped for an unprecedented seventh consecutive year. The bubble wont vanish overnight.

Pharmacy

Drug Channels

JUNE 17, 2025

This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: What’s Next for Retail Pharmacy: Data, Debate, and Disruption. Three’s still company in the world of pharmacy benefit managers. Read more » © 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company.

Pharmacy

Drug Channels

JUNE 19, 2025

This week, I’m rerunning some popular posts while I prepare for tomorrow's live video webinar: What’s Next for Retail Pharmacy: Data, Debate, and Disruption. It's time for Drug Channels ’ annual update of vertical integration among insurers, PBMs, specialty pharmacies, and healthcare services within U.S. drug channels.

Specialty Pharmacies

Drug Channels

APRIL 1, 2025

For 2025, the three largest pharmacy benefit managers (PBMs)Caremark (CVS Health), Express Scripts (Cigna), and Optum Rx (United Health Group)have again each excluded hundreds of drugs from their standard formularies. I encourage you to share your thoughts with the Drug Channels community on LinkedIn. What do you think?

Biosimilars

Drug Channels

MAY 28, 2025

Whats Next for Retail Pharmacy: Data, Debate, and Disruption. Well unpack the good, the bad, and the ugly of the pharmacy industryand explore what it means for you. Read more 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. ET), featuring Dr. Adam J. Fein and Antonio Ciaccia.

Pharmacy

Drug Channels

APRIL 23, 2025

Last week, we examined the growing concentration of specialty drug dispensing revenues among the largest pharmacies. See The Top 15 Specialty Pharmacies of 2024: How PBMs, Health Systems, and Independents Are Shaping the Market. Read more 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company.

Pharmacy

Drug Channels

DECEMBER 3, 2024

Minnesota just released the industry‘s first ever mandated financial report on the 340B Drug Pricing Program. Below, I do a wicked deep dive into the data and highlight crucial implications about spending, profits, pharmacies, plans, patients, program integrity, and more. It’s time to pay attention to the money behind the 340B curtain.

Pharmacy

Perficient: Drug Development

FEBRUARY 11, 2025

Why Drug Companies’ Web Pages and Mobile Applications Should Be Accessible for Screen Reader Users In today’s digital landscape, ensuring that online platforms are accessible to everyone is not just a legal requirement, but also a moral imperative. This enhances the usability of the digital platform.

Pharmacy

Drug Channels

JUNE 16, 2025

This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: What’s Next for Retail Pharmacy: Data, Debate, and Disruption. Next week, Drug Channels Institute (DCI) will release our 2025 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. All rights reserved.

Specialty Pharmacies

Drug Channels

MAY 16, 2025

Divya shares new GoodRx data showing that out-of-pocket costs at the pharmacy counter remain a primary barrier to medication adherence. To learn about GoodRxs prescription abandonment solutions, download Reduce Rx Abandonment at the Pharmacy. Read on for Divyas insights. Read on for Divyas insights. All rights reserved.

Pharmacy

Drug Channels

FEBRUARY 18, 2025

Small pharmacies have ghosted Medicare Part Ds preferred networksno farewell party, no breakup text, just a quiet exit. A few months ago , DCI highlighted how the largest pharmacy chains are participating as preferred cost sharing pharmacies in the 2025 stand-alone prescription drug plan (PDP) networks. Abracadabra!

Pharmacy

Drug Channels

JUNE 20, 2025

This week, I’m rerunning some popular posts while I prepare for today’s live video webinar: What’s Next for Retail Pharmacy: Data, Debate, and Disruption. Since 2017, 24 states have passed 38 laws targeting healthcare transparency , with a strong focus on unraveling the complex economics of pharmacy benefit managers (PBMs).

Pharmacy

Drug Channels

MARCH 5, 2025

Since 2017, 24 states have passed 38 laws targeting healthcare transparency , with a strong focus on unraveling the complex economics of pharmacy benefit managers (PBMs). Read more 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Click here to learn more and sign up. All rights reserved.

Pharmacy

Drug Channels

MAY 20, 2025

Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCIs new live video webinar: Whats Next for Retail Pharmacy: Data, Debate, and Disruption This event will be broadcast live on: Friday, June 20, 2025 12:00 p.m. It is part of The Drug Channels 2025 Video Webinar Series.

Pharmacy

Drug Channels

APRIL 15, 2025

Whether you're building trust with customers, launching new products, or guiding internal teams, understanding the economic forces that shape drug distribution, reimbursement, and pricing is essential. Understand reimbursement dynamics, cost estimation methods, and how profitability varies across drug types and dispensing models.

Specialty Pharmacies

Drugs.com

OCTOBER 3, 2024

3, 2024 -- Americans who turn to online pharmacies to find cheaper versions of expensive prescription medications, especially opioids, may instead be buying themselves dangerous drugs that could trigger an overdose, U.S. THURSDAY, Oct.

Online Pharmacies

Drug Channels

JUNE 3, 2025

Its time for Drug Channels annual look at pharmacist salaries and employment. There was more bad news, as employment in retail pharmacies and drugstores dropped by 8,500 positions in 2024, following a drop of 4,800 positions in 2023. Employment in mass merchants and supermarkets with pharmacies increased. Dr. Adam J.

Hospitals